A review on fatty liver disease or non-alcoholic fatty liver disease and hepatocellular carcinoma

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F21%3AE0109546" target="_blank" >RIV/00843989:_____/21:E0109546 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61988987:17110/21:A2302CIC

Výsledek na webu

<a href="https://worldresearchersassociations.com/Archives/RJBT/Vol(16)2021//October%202021/A%20review%20on%20fatty%20liver%20disease%20or%20non-alcoholic.pdf" target="_blank" >https://worldresearchersassociations.com/Archives/RJBT/Vol(16)2021//October%202021/A%20review%20on%20fatty%20liver%20disease%20or%20non-alcoholic.pdf</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

A review on fatty liver disease or non-alcoholic fatty liver disease and hepatocellular carcinoma

Popis výsledku v původním jazyce

The non-alcoholic fatty liver disease (NAFLD) is the predominant etiological factor for liver disease. There is a risk of the development of hepatocellular carcinoma (HCC) in patients suffering from NAFLD. Non-alcoholic steatohepatitis (NASH) is one of the risk factors for the development of HCC. The aim is to discuss an association of NAFLD and HCC in the adult population. HCC is one of the debilitating complications of NAFLD/NASH and obesity is a causative factor for NAFLD/NASH. Various clinical data suggest that obesity appears to be a causative factor in the progression of NAFLD/NASH to HCC. We searched data from the PubMed/Medline and Google Scholar databases including various studies and review articles. Significantly, an increased number of HCC patients with cryptogenic liver disease had well-differentiated tumors than in HCC patients with chronic viral hepatitis and alcoholism. HCC is one of the debilitating complications of NAFLD/NASH and obesity is a causative factor for NAFLD/NASH. Various preclinical and clinical data suggest that obesity appears to be an important causative factor in the progression of NAFLD/NASH to HCC.

Název v anglickém jazyce

A review on fatty liver disease or non-alcoholic fatty liver disease and hepatocellular carcinoma

Popis výsledku anglicky

The non-alcoholic fatty liver disease (NAFLD) is the predominant etiological factor for liver disease. There is a risk of the development of hepatocellular carcinoma (HCC) in patients suffering from NAFLD. Non-alcoholic steatohepatitis (NASH) is one of the risk factors for the development of HCC. The aim is to discuss an association of NAFLD and HCC in the adult population. HCC is one of the debilitating complications of NAFLD/NASH and obesity is a causative factor for NAFLD/NASH. Various clinical data suggest that obesity appears to be a causative factor in the progression of NAFLD/NASH to HCC. We searched data from the PubMed/Medline and Google Scholar databases including various studies and review articles. Significantly, an increased number of HCC patients with cryptogenic liver disease had well-differentiated tumors than in HCC patients with chronic viral hepatitis and alcoholism. HCC is one of the debilitating complications of NAFLD/NASH and obesity is a causative factor for NAFLD/NASH. Various preclinical and clinical data suggest that obesity appears to be an important causative factor in the progression of NAFLD/NASH to HCC.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30212 - Surgery

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Research journal of biotechnology

ISSN

2278-4535

e-ISSN

2278-4535

Svazek periodika

16

Číslo periodika v rámci svazku

10

Stát vydavatele periodika

IN - Indická republika

Počet stran výsledku

7

Strana od-do

156-162

Kód UT WoS článku

000702072800020

EID výsledku v databázi Scopus

2-s2.0-85115745963